Pharmaceutical technologies
Prevention, treatment and wellness
Antibiotics
β-lactam product
| Active principle | Fharmaceutical Form |
| Piperacillin / Tazobactam 4,5 g | 50 ml perfusion vial |
| Piperacillin / Tazobactam 3,375 | 20 ml perfusion vial |
| Piperacillin / Tazobactam 2,25 g | 20 ml perfusion vial |
Injectable products
Freeze-dried products
| Active principle | Fharmaceutical Form |
| Remifentanil 1 mg | 3 ml lyophilized vial for injection |
| Remifentanil 2 mg | 3 ml lyophilized vial for injection |
| Remifentanil 5 mg | 6 ml lyophilized vial for injection |
| Ganciclovir 500 mg | 10 ml lyophilized vial for injection |
| Bivalirudin 250 mg | 10 ml lyophilized vial for injection |
| Pemetrexed 100 mg | 10 ml lyophilized vial for injection |
| Pemetrexed 500 mg | 50 ml lyophilized vial for injection |
| Anidulafungin 100 m | Lyophilized vial for injection |
Liquids for injection
| Active principle | Fharmaceutical Form |
| Palonosetron 0,25 mg | 5 ml solution for injection |
Others
Oral solution
| Active principle | Fharmaceutical Form |
| Sodium Oxybate 500mg/ml | Oral solution |